Biopharmaceutical News and Research

RSS
Santarus's budesonide MMX drug shows positive result for active ulcerative colitis

Santarus's budesonide MMX drug shows positive result for active ulcerative colitis

8 Nov 2010
BioSpecifics Technologies third quarter net loss increases to $0.5 million

BioSpecifics Technologies third quarter net loss increases to $0.5 million

8 Nov 2010
GeoVax receives $244,500 grant under QTDP program for HIV/AIDS vaccine development

GeoVax receives $244,500 grant under QTDP program for HIV/AIDS vaccine development

8 Nov 2010
Oragenics awarded $733,437 Federal Grant under PPACA Act

Oragenics awarded $733,437 Federal Grant under PPACA Act

8 Nov 2010
Agios receives two grants under QTDP program to develop novel cancer metabolism therapies

Agios receives two grants under QTDP program to develop novel cancer metabolism therapies

8 Nov 2010
Eleven Biotherapeutics receives QTDP grants for lead protein-based discovery programs

Eleven Biotherapeutics receives QTDP grants for lead protein-based discovery programs

8 Nov 2010
Provectus presents PV-10 Phase 2 clinical trial data for metastatic melanoma at Sydney Congress

Provectus presents PV-10 Phase 2 clinical trial data for metastatic melanoma at Sydney Congress

8 Nov 2010
Omeros third quarter net loss increases to $7.6 million

Omeros third quarter net loss increases to $7.6 million

4 Nov 2010
Halozyme awarded $977,917 grant under Qualifying Therapeutic Discovery Project program

Halozyme awarded $977,917 grant under Qualifying Therapeutic Discovery Project program

4 Nov 2010
Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

Synta reports $10.3M net loss for third quarter 2010 vs. $118.1M net income for third quarter 2009

4 Nov 2010
Rockwell Medical third quarter sales increases 4.1% to $14.7 million

Rockwell Medical third quarter sales increases 4.1% to $14.7 million

4 Nov 2010
AVEO third quarter total collaboration revenues increase to $6.2 million

AVEO third quarter total collaboration revenues increase to $6.2 million

4 Nov 2010
PDI announces acquisition of Group DCA

PDI announces acquisition of Group DCA

4 Nov 2010
Advanced Life Sciences awarded $244,479.25 grant under Qualifying Therapeutic Discovery Project

Advanced Life Sciences awarded $244,479.25 grant under Qualifying Therapeutic Discovery Project

4 Nov 2010
Regado receives funding under QTDP grant program to advance treatment for cardiovascular diseases

Regado receives funding under QTDP grant program to advance treatment for cardiovascular diseases

4 Nov 2010
Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

4 Nov 2010
PIKAMAB awarded QTDP program grants to advance development of theragnostic products

PIKAMAB awarded QTDP program grants to advance development of theragnostic products

4 Nov 2010
Acceleron receives grants for five projects under QTDP program

Acceleron receives grants for five projects under QTDP program

4 Nov 2010
Cocrystal receives $733,438 in grants from QTDP program

Cocrystal receives $733,438 in grants from QTDP program

4 Nov 2010
SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

SurModics and Edge Therapeutics enter licensing agreement for drug delivery technology

4 Nov 2010

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback